Have a personal or library account? Click to login
Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer Cover

Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer

PRILOZI
Volume 38 (2017): Issue 3 (December 2017)
By: Marija Petrusevska,  Irina Panovska Stavridis,  Kristina Mladenovska and  Gordana Petrushevska  
Open Access
|Apr 2018

Authors

Marija Petrusevska

mapet85@yahoo.com

Institute of preclinical and clinical pharmacology and toxicology, Faculty of Medicine, University “Ss. Cyril and Methodius”, Skopje

Irina Panovska Stavridis

University Clinic of hematology, University “Ss. Cyril and Methodius”, Skopje

Kristina Mladenovska

Department of clinical pharmacy, Faculty of Pharmacy, University “Ss. Cyril and Methodius”, Skopje

Gordana Petrushevska

Institute of pathology, Faculty of Medicine, University “Ss. Cyril and Methodius”, Skopje
DOI: https://doi.org/10.2478/prilozi-2018-0010 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 97 - 103
Published on: Apr 16, 2018
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Hodgkin lymphoma,
MDS,
Castleman disease paclitaxel,
carboplatin
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2018 Marija Petrusevska, Irina Panovska Stavridis, Kristina Mladenovska, Gordana Petrushevska, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 38 (2017): Issue 3 (December 2017)Next article